Mechanisms of resistance to crizotinib in patients with ALK gene rearranged non-small-cell lung cancer.
Division of Oncology, Department of Oncology, Azienda USL-6 of Livorno, Italy. tiby@katamail.com.
Carmelo
C
Tibaldi